Keywords: chiron, il-2, melanoma, presented, data, use, its

Chiron's IL-2 In Melanoma

Article | 30 May 1997

Print This

- Chiron presented data on the use of its interleukin-2 productProleukin (aldesleukin) in the treatment of malignant melanoma. High doses of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in